<?xml version="1.0" encoding="UTF-8"?>
<table id="PMC5065164/table_4" xmlns="http://www.w3.org/1999/xhtml">
 <caption>
  <label>Table 4</label>
  <title>Resource use associated with boceprevir and telaprevir.</title>
 </caption>
 <colgroup span="1">
  <col align="left" valign="middle" span="1"/>
  <col align="left" valign="middle" span="1"/>
  <col align="left" valign="middle" span="1"/>
 </colgroup>
 <thead>
  <tr>
   <th align="left" rowspan="1" colspan="1" id="0-0-."/>
   <th align="left" rowspan="1" colspan="1" id="0-1-.">Boceprevir (n = 25)</th>
   <th align="left" rowspan="1" colspan="1" id="0-2-.">Telaprevir (n = 25)</th>
  </tr>
 </thead>
 <tbody>
  <tr>
   <td align="left" rowspan="1" colspan="1">
    <b>Routine care</b>
   </td>
   <td align="center" rowspan="1" colspan="1"/>
   <td align="center" rowspan="1" colspan="1"/>
  </tr>
  <tr>
   <td align="left" rowspan="1" colspan="1"> • Cost for Routine care NP/physician/PharmD/MH visits</td>
   <td align="char" char="." rowspan="1" colspan="1">$31,823.00</td>
   <td align="char" char="." rowspan="1" colspan="1">$25,168.00</td>
  </tr>
  <tr>
   <td align="left" rowspan="1" colspan="1"> • Routine drugs cost (PI/Peg-IFN/RBV)</td>
   <td align="char" char="." rowspan="1" colspan="1">$440,997.78</td>
   <td align="char" char="." rowspan="1" colspan="1">$648,884.00</td>
  </tr>
  <tr>
   <td align="left" rowspan="1" colspan="1"> • Total routine care cost per person</td>
   <td align="char" char="." rowspan="1" colspan="1">$18,912.83</td>
   <td align="char" char="." rowspan="1" colspan="1">$26,962.08</td>
  </tr>
  <tr>
   <td align="left" rowspan="1" colspan="1">
    <b>Additional care</b>
   </td>
   <td align="center" rowspan="1" colspan="1"/>
   <td align="center" rowspan="1" colspan="1"/>
  </tr>
  <tr>
   <td align="left" rowspan="1" colspan="1"> • Cost for extra evaluation due to AE 
    <a ref-type="table-fn" rid="t004fn001">*</a>
   </td>
   <td align="char" char="." rowspan="1" colspan="1">$2,260.00</td>
   <td align="char" char="." rowspan="1" colspan="1">$11,330.00</td>
  </tr>
  <tr>
   <td align="left" rowspan="1" colspan="1"> • Drugs used for treatment of AE (Epo+Fil)</td>
   <td align="char" char="." rowspan="1" colspan="1">$12,541.00</td>
   <td align="char" char="." rowspan="1" colspan="1">$13,264.00</td>
  </tr>
  <tr>
   <td align="left" rowspan="1" colspan="1"> • Cost of adverse events per study arm</td>
   <td align="char" char="." rowspan="1" colspan="1">$14,801.00</td>
   <td align="char" char="." rowspan="1" colspan="1">$24,594.00</td>
  </tr>
  <tr>
   <td align="left" rowspan="1" colspan="1">
    <b>Total treatment cost per SVR</b>
   </td>
   <td align="char" char="." rowspan="1" colspan="1">$44,329.25</td>
   <td align="char" char="." rowspan="1" colspan="1">$57,115.17</td>
  </tr>
 </tbody>
 <tfoot>
  <p class="fn" charset="fn" id="t004fn001">
   <p>*Outpatient evaluation by nurse practitioner, pharmacist, mental health provider, emergency department evaluations, hospitalizations</p>
  </p>
  <p class="fn" charset="fn" id="t004fn002">
   <p>Epo: epoetin-α; Fil: filgrastim; PI: Protease Inhibitor; AE: Adverse Event; MH: Mental Health; NP: Nurse Practitioner; PharmD: Clinical Pharmacist; Peg-IFN: Pegylated Interferon; RBV: Ribavirin; SVR: Sustained virologic response.</p>
  </p>
 </tfoot>
</table>
